NovaBay Pharmaceuticals, Inc.

NYSEAM:NBY Stock Report

Market Cap: US$3.3m

NovaBay Pharmaceuticals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Justin Hall

Chief executive officer

US$365.0k

Total compensation

CEO salary percentage95.9%
CEO tenure8.3yrs
CEO ownership0.008%
Management average tenureno data
Board average tenure3.9yrs

Recent management updates

Recent updates

We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Mar 29
We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

CEO Compensation Analysis

How has Justin Hall's remuneration changed compared to NovaBay Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$17m

Sep 30 2023n/an/a

-US$16m

Jun 30 2023n/an/a

-US$20m

Mar 31 2023n/an/a

-US$18m

Dec 31 2022US$365kUS$350k

-US$16m

Sep 30 2022n/an/a

-US$9m

Jun 30 2022n/an/a

-US$5m

Mar 31 2022n/an/a

-US$5m

Dec 31 2021US$796kUS$329k

-US$7m

Sep 30 2021n/an/a

-US$7m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$747kUS$286k

-US$11m

Sep 30 2020n/an/a

-US$13m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$8m

Dec 31 2019US$326kUS$260k

-US$10m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$10m

Mar 31 2019n/an/a

-US$9m

Dec 31 2018US$572kUS$260k

-US$7m

Sep 30 2018n/an/a

-US$4m

Jun 30 2018n/an/a

-US$5m

Mar 31 2018n/an/a

-US$6m

Dec 31 2017US$665kUS$228k

-US$7m

Compensation vs Market: Justin's total compensation ($USD364.95K) is below average for companies of similar size in the US market ($USD662.11K).

Compensation vs Earnings: Justin's compensation has been consistent with company performance over the past year.


CEO

Justin Hall (45 yo)

8.3yrs

Tenure

US$364,954

Compensation

Mr. Justin M. Hall, Esq. has been General Counsel at NovaBay Pharmaceuticals, Inc. since December 2015, Corporate Secretary since July 16, 2017 and President and Chief Executive Officer since June 17, 2019...


Board Members

NamePositionTenureCompensationOwnership
Justin Hall
President3.6yrsUS$364.95k0.0079%
$ 264.5
Paul Freiman
Independent Chairman21.8yrsUS$82.99k0.0059%
$ 198.2
Yenyou Zheng
Independent Director4.5yrsUS$78.99k0.0057%
$ 190.8
Mijia Wu
Director8.2yrsUS$45.49k0.0057%
$ 190.8
Ahmad Fahmy
Member of Optometry Advisory Board9.2yrsno datano data
Pedram Hamrah
Member of Ophthalmic Advisory Board8.4yrsno datano data
Swan Sit
Independent Director4.3yrsUS$63.99k0.0057%
$ 190.8
Mark Cheung
Member of the Optometry Advisory Board3.3yrsno datano data
Guru Sharma
Member of the Optometry Advisory Board3.3yrsno datano data
Komal Thakore
Member of the Optometry Advisory Board3.3yrsno datano data
Suzanne Sherman
Member of the Optometry Advisory Board3.3yrsno datano data
Jerry Robben
Member of the Optometry Advisory Board3.3yrsno datano data

3.9yrs

Average Tenure

49yo

Average Age

Experienced Board: NBY's board of directors are considered experienced (3.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.